1,162
Views
37
CrossRef citations to date
0
Altmetric
Review Article

Strategies in Ebola virus disease (EVD) diagnostics at the point of care

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 779-798 | Received 07 Jul 2016, Accepted 25 Mar 2017, Published online: 25 Apr 2017

References

  • Akter F, Mie M, Kobatake E. 2014. DNA-based immunoassays for sensitive detection of protein. Sens Actuators B Chem. 202:1248–1256.
  • Alazard-Dany N, Terrangle MO, Volchkov V. 2006. Ebola et Marburg: les hommes contre-attaquent. M/S: Méd Sci. 22:405–410.
  • Asghar W, El Assal R, Shafiee H, Pitteri S, Paulmurugan R, Demirci U. 2015. Engineering cancer microenvironments for in vitro 3-D tumor models. Mater Today. 18:539–553.
  • Asghar W, Ilyas A, Billo JA, Iqbal SM. 2011. Shrinking of solid-state nanopores by direct thermal heating. Nanoscale Res Lett. 6:1–6.
  • Asghar W, Ilyas A, Deshmukh RR, Sumitsawan S, Timmons RB, Iqbal SM. 2011. Pulsed plasma polymerization for controlling shrinkage and surface composition of nanopores. Nanotechnology. 22:285304.
  • Asghar W, Ramachandran PP, Adewumi A, Noor MR, Iqbal SM. 2010. Rapid nanomanufacturing of metallic break junctions using focused ion beam scratching and electromigration. J Manuf Sci Eng. 132:030911.
  • Asghar W, Wan Y, Ilyas A, Bachoo R, Kim Y-T, Iqbal SM. 2012. Electrical fingerprinting, 3D profiling and detection of tumor cells with solid-state micropores. Lab Chip. 12:2345–2352.
  • Asghar W, Yuksekkaya M, Shafiee H, Zhang M, Ozen MO, Inci F, Kocakulak M, Demirci U. 2016. Engineering long shelf life multi-layer biologically active surfaces on microfluidic devices for point of care applications. Sci Rep. 6.Article: 21163
  • Aylward B, Barboza P, Bawo L, Bertherat E, Bilivogui P, Blake I. 2014. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med. 371:1481–1495.
  • Barletta J. 2006. Applications of real-time immuno-polymerase chain reaction (rt-IPCR) for the rapid diagnosis of viral antigens and pathologic proteins. Mol Asp Med. 27:224–253.
  • Bausch DG, Schwarz L. 2014. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis. 8:e3056.
  • Bhalla N, Chung DWY, Chang Y-J, Uy KJS, Ye YY, Chin T-Y, Yang HC, Pijanowska DG. 2013. Microfluidic platform for enzyme-linked and magnetic particle-based immunoassay. Micromachines. 4:257–271.
  • Binning JM, Wang T, Luthra P, Shabman RS, Borek DM, Liu G, Xu W, Leung DW, Basler CF, Amarasinghe GK. 2013. Development of rna aptamers targeting ebola virus vp35. Biochemistry. 52:8406–8419.
  • Bouree P, Bergmann J-F. 1983. Ebola virus infection in man: a serological and epidemiological survey in the Cameroons. Am J Trop Med Hyg. 32:1465–1466.
  • Brandt O, Hoheisel JD. 2004. Peptide nucleic acids on microarrays and other biosensors. TRENDS Biotechnol. 22:617–622.
  • Broadhurst MJ, Brooks TJ, Pollock NR. 2016. Diagnosis of Ebola virus disease: past, present, and future. Clin Microbiol Rev. 29:773–793.
  • Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, Simpson A, Brooks T, Hula S, Nyoni W, et al. 2015. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 386:867–874.
  • Cai H, Parks JW, Carrion R, Zempoaltecatl L, Patterson JP, Hawkins A, Schmidt H. 2014. On-chip detection of clinical Ebola virus RNA using specific DNA binding technique. Proceedings of the CLEO: Science and Innovations. Optical Society of America.
  • Cavallo MF, Kats AM, Chen R, Hartmann JX, Pavlovic M; Bioterrorism Agents/Diseases. 2012. A novel method for real-time, continuous, fluorescence-based analysis of anti-DNA abzyme activity in systemic lupus. Autoimmune Dis. 2012. Available from http://www.bt.cdc.gov/agent/agentlist-category.asp
  • Chambers JP, Arulanandam BP, Matta LL, Weis A, Valdes JJ. 2008. Biosensor recognition elements. Curr Issues Mol Biol. 10:1–12.
  • Changula K, Yoshida R, Noyori O, Marzi A, Miyamoto H, Ishijima M, Yokoyama A, Kajihara M, Feldmann H, Mweene AS, et al. 2013. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein. Virus Res. 176:83–90.
  • Chen L, Wei H, Guo Y, Cui Z, Zhang Z, Zhang X-E. 2009. Gold nanoparticle enhanced immuno-PCR for ultrasensitive detection of Hantaan virus nucleocapsid protein. J Immun Meth. 346:64–70.
  • Cherpillod P, Schibler M, Vieille G, Cordey S, Mamin A, Vetter P, Kaiser L. 2016. Ebola virus disease diagnosis by real-time RT-PCR: a comparative study of 11 different procedures. J Clin Virol. 77:9–14.
  • Chomczynski P. 1994. Shelf-stable product and process for isolating RNA, DNA and proteins. Google Patents.
  • Chua AC, Cunningham J, Moussy F, Perkins MD, Formenty P. 2015. The case for improved diagnostic tools to control Ebola virus disease in West Africa and how to get there. PLoS Negl Trop Dis. 119:e0003734.
  • Cooper MA. 2002. Optical biosensors in drug discovery. Nat Rev Drug Discov. 1:515–528.
  • Cooper MA, Singleton VT. 2007. A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions. J Mol Recogn. 20:154–184.
  • Dantham VR, Holler S, Barbre C, Keng D, Kolchenko V, Arnold S. 2013. Label-free detection of single protein using a nanoplasmonic-photonic hybrid microcavity. Nano Lett. 13:3347–3351.
  • Dhillon RS, Srikrishna D, Garry RF, Chowell G. 2015. Ebola control: rapid diagnostic testing. Lancet Infect Dis. 15:147–148.
  • Dhillon RS, Srikrishna D, Sachs J. 2014. Controlling Ebola: next steps. Lancet. 384:1409–1411.
  • Diagnosis: Ebola hemorrhagic fever. 14 November 2014. 2014 Ebola outbreak in West Africa – case counts [Internet]. [cited 2016 Mar 4]. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html
  • Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol. 40:2323–2330.
  • Esiobu N, Mohammed R, Echeverry A, Green M, Bonilla T, Hartz A, McCorquodale D, Rogerson A. 2004. The application of peptide nucleic acid probes for rapid detection and enumeration of eubacteria, Staphylococcus aureus and Pseudomonas aeruginosa in recreational beaches of S. Florida. J Microbiol Methods. 57:157–162.
  • Falzarano D, Krokhin O, Wahl‐Jensen V, Seebach J, Wolf K, Schnittler HJ, Feldmann H. 2006. Structure–function analysis of the soluble glycoprotein, sGP, of Ebola virus. Chembiochem. 7:1605–1611.
  • Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet. 377:849–862.
  • Flint M, Goodman CH, Bearden S, Blau DM, Amman BR, Basile AJ, Belser JA, Bergeron E, Bowen MD, Brault AC, et al. 2015. Ebola Virus Diagnostics: The US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015. J Infect Dis. 212 Suppl 2:S350–S358.
  • Garcia-Schwarz G, Rogacs A, Bahga SS, Santiago JG. 2012. On-chip isotachophoresis for separation of ions and purification of nucleic acids. J Vis Exp. 61:e3890.
  • Gaster RS, Hall DA, Wang SX. 2011. nanoLAB: an ultraportable, handheld diagnostic laboratory for global health. Lab Chip. 11:950–956.
  • Gibb TR, Norwood DA, Woollen N, Henchal EA. 2001. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J Clin Microbiol. 39:4125–4130.
  • Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 345:1369–1372.
  • Grolla A, Lucht A, Dick D, Strong J, Feldmann H. 2005. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull – Soc Pathol Exotique. 98:205.
  • Guidance for U.S. laboratories for managing and testing routine clinical specimens when there is a concern about Ebola virus disease [Internet]. [cited 2015 Nov 10]. Available from: http://www.cdc.gov/vhf/ebola/healthcare-us/laboratories/safe-specimen-management.html
  • Günther S, Asper M, Röser C, Luna LKS, Drosten C, Becker-Ziaja B, Borowski P, Chen H-M, Hosmane RS. 2004. Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro. Antiviral Res. 63:209–215.
  • Guo MT, Rotem A, Heyman JA, Weitz DA. 2012. Droplet microfluidics for high-throughput biological assays. Lab Chip. 12:2146–2155.
  • Hafeez A, Asghar W, Rafique MM, Iqbal SM, Butt AR. 2012. GPU-based real-time detection and analysis of biological targets using solid-state nanopores. Med Biol Eng Comput. 50:605–615.
  • Heid CA, Stevens J, Livak KJ, Williams PM. 1996. Real time quantitative PCR. Genome Res. 6:986–994.
  • Hirsch LR, Jackson JB, Lee A, Halas NJ, West JL. 2003. A whole blood immunoassay using gold nanoshells. Anal Chem. 75:2377–2381.
  • Huang Y, Wei H, Wang Y, Shi Z, Raoul H, Yuan Z. 2012. Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays. Virol Sin. 27:273–277.
  • Ikegami T, Saijo M, Niikura M, Miranda M, Calaor A, Hernandez M, Manalo D, Kurane I, Yoshikawa Y, Morikawa S. 2003. Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus. Epidemiol Infect. 130(3):533–539
  • Ilyas A, Asghar W, Ahmed S, Lotan Y, Hsieh J-T, Kim Y-T, Iqbal SM. 2014. Electrophysiological analysis of biopsy samples using elasticity as an inherent cell marker for cancer detection. Anal Methods. 6:7166–7174.
  • Ilyas A, Asghar W, Allen PB, Duhon H, Ellington AD, Iqbal SM. 2012. Electrical detection of cancer biomarker using aptamers with nanogap break-junctions. Nanotechnology. 23:275502.
  • Ilyas A, Asghar W, Kim Y-t, Iqbal SM. 2014. Parallel recognition of cancer cells using an addressable array of solid-state micropores. Biosens Bioelectron. 62:343–349.
  • Jung B, Ness K, Rose KA. 2011. Methods for separating particles and/or nucleic acids using isotachophoresis. Google Patents.
  • Kallstrom G, Warfield KL, Swenson DL, Mort S, Panchal RG, Ruthel G, Bavari S, Aman MJ. 2005. Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol Methods. 127:1–9.
  • Kalra S, Kelkar D, Galwankar SC, Papadimos TJ, Stawicki SP, Arquilla B, Hoey BA, Sharpe RP, Sabol D, Jahre JA. 2014. The emergence of ebola as a global health security threat: from ‘lessons learned’ to coordinated multilateral containment efforts. J Global Infect Dis. 6:164.
  • Kamata T, Natesan M, Warfield K, Aman MJ, Ulrich RG. 2014. Determination of specific antibody responses to the six species of Ebola and Marburg viruses by multiplexed protein microarrays. Clin Vaccine Immunol. 21:1605–1612.
  • Khandurina J, McKnight TE, Jacobson SC, Waters LC, Foote RS, Ramsey JM. 2000. Integrated system for rapid PCR-based DNA analysis in microfluidic devices. Anal Chem. 72:2995–3000.
  • Kierny MR, Cunningham TD, Kay BK. 2012. Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms. Nano Rev Exp. 3:17240.
  • Kiselinova M, Pasternak AO, De Spiegelaere W, Vogelaers D, Berkhout B, Vandekerckhove L. 2014. Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA. PLoS One. 9:e85999.
  • Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, et al. 1999. Clinical virology of Ebola Hemorrhagic Fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 179:S177–S187.
  • Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters C. 1999. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 179:S192–S198.
  • Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST. 2010. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol. 155:2083–2103.
  • Kurosaki Y, Takada A, Ebihara H, Grolla A, Kamo N, Feldmann H, Kawaoka Y, Yasuda J. 2007. Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. J Virol Methods. 141:78–83.
  • Lagally ET, Emrich CA, Mathies RA. 2001. Fully integrated PCR-capillary electrophoresis microsystem for DNA analysis. Lab Chip. 1:102–107.
  • Le Roux C, Kubo T, Grobbelaar AA, van Vuren PJ, Weyer J, Nel LH, Swanepoel R, Morita K, Paweska JT. 2009. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens. J Clin Microbiol. 47:645–651.
  • Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177–182.
  • Lee JE, Saphire EO. 2009. Ebola virus glycoprotein structure and mechanism of entry. Future Virol. 4:621–635.
  • Leroy EM, Baize S, Lu CY, McCormick JB, Georges AJ, Georges-Courbot MC, Lansoud-Soukate J, Fisher-Hoch SP. 2000. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol. 60:463–467.
  • Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, Georges AJ, McCormick JB. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 355:2210–2215.
  • Levesque-Sergerie J-P, Duquette M, Thibault C, Thibault C, Delbecchi L, Bissonnette N. 2007. Detection limits of several commercial reverse transcriptase enzymes: impact on the low- and high-abundance transcript levels assessed by quantitative RT-PCR. BMC Mol Biol. 8:93.
  • Li X, Morgenroth E, Raskin L. 2008. Quantitative rRNA-targeted solution-based hybridization assay using peptide nucleic acid molecular beacons. Appl Environ Microbiol. 74:7297–7305.
  • Lien K-Y, Hung L-Y, Huang T-B, Tsai Y-C, Lei H-Y, Lee G-B. 2011. Rapid detection of influenza A virus infection utilizing an immunomagnetic bead-based microfluidic system. Biosens Bioelectron. 26:3900–3907.
  • Liu D, Shi M, Huang H, Long Z, Zhou X, Qin J, Lin B. 2006. Isotachophoresis preconcentration integrated microfluidic chip for highly sensitive genotyping of the hepatitis B virus. J Chromatogr B. 844:32–38.
  • Lucht A, Formenty P, Feldmann H, Götz M, Leroy E, Bataboukila P, Grolla A, Feldmann F, Wittmann T, Campbell P. 2007. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. J Infect Dis. 196:S184–S192.
  • Lucht A, Grunow R, Möller P, Feldmann H, Becker S. 2003. Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. J Virol Methods. 111:21–28.
  • Lucht A, Grunow R, Otterbein C, Möller P, Feldmann H, Becker S. 2004. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol. 193:181–187.
  • Lutz S, Weber P, Focke M, Faltin B, Hoffmann J, Muller C, Mark D, Roth G, Munday P, Armes N, et al. 2010. Microfluidic lab-on-a-foil for nucleic acid analysis based on isothermal recombinase polymerase amplification (RPA). Lab Chip. 10:887–893.
  • Malou N, Raoult D. 2011. Immuno-PCR: a promising ultrasensitive diagnostic method to detect antigens and antibodies. Trends Microbiol. 19:295–302.
  • Marshall LA, Han CM, Santiago JG. 2011. Extraction of DNA from malaria-infected erythrocytes using isotachophoresis. Anal Chem. 83:9715–9718.
  • Miller R. 1990. Update: filovirus infections among persons with occupational exposure to nonhuman primates. MMWR Morb Mortal Wkly Rep.;39:266–267.
  • Mori Y, Notomi T. 2009. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J Infect Chemother. 15:62–69.
  • Morikawa S, Saijo M, Kurane I. 2007. Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston). Comp Immunol Microbiol Infect Dis. 30:391–398.
  • Morin I, Schaeffer PM. 2012. Combining RNA–DNA swapping and quantitative polymerase chain reaction for the detection of influenza A nucleoprotein. Anal Biochem. 420:121–126.
  • Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, Matsuno K, Marzi A, Feldmann H, Ito K, Saijo M. 2010. Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin Vaccine Immunol. 17:1723–1728.
  • Nanbo A, Watanabe S, Halfmann P, Kawaoka Y. 2013. The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Sci Rep. 3:1206.
  • Niikura M, Ikegami T, Saijo M, Kurane I, Miranda ME, Morikawa S. 2001. Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. J Clin Microbiol. 39:3267–3271.
  • Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. 2000. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28:E63.
  • Ostromohov N, Schwartz O, Bercovici M. 2015. Focused upon hybridization: rapid and high sensitivity detection of DNA using isotachophoresis and peptide nucleic acid probes. Anal Chem. 87:9459–9466.
  • Pardee K, Green AA, Ferrante T, Cameron DE, DaleyKeyser A, Yin P, Collins JJ. 2014. Paper-based synthetic gene networks. Cell. 159:940–954.
  • Patolsky F, Zheng G, Hayden O, Lakadamyali M, Zhuang X, Lieber CM. 2004. Electrical detection of single viruses. Proc Natl Acad Sci USA. 101:14017–14022.
  • Pavlovic M, Chen R, Kats AM, Cavallo MF, Saccocio S, Keating P, Hartmann JX. 2007. Highly specific novel method for isolation and purification of Lupus anti‐DNA antibody via Oligo‐(dT) magnetic beads. Ann N Y Acad Sci. 1108:203–217.
  • Perkins MD, Kessel M. 2015. What Ebola tells us about outbreak diagnostic readiness. Nat Biotechnol. 33:464–469.
  • Persat A, Marshall LA, Santiago JG. 2009. Purification of nucleic acids from whole blood using isotachophoresis. Anal Chem. 81:9507–9511.
  • Pettitt J, Higgs ES, Adams RD, Jahrling PB, Hensley LE. 2016. Use of existing diagnostic RT-PCR assays for detection of Ebola virus RNA in semen. J Infect Dis. 213:1237–1239.
  • Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
  • Porter-Jordan K, Rosenberg EI, Keiser JF, Gross JD, Ross AM, Nasim S, Garrett CT. 1990. Nested polymerase chain reaction assay for the detection of cytomegalovirus overcomes false positives caused by contamination with fragmented DNA. J Med Virol. 30:85–91.
  • Prehaud C, Hellebrand E, Coudrier D, Volchkov V, Volchkova V, Feldmann H, Le Guenno B, Bouloy M. 1998. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol. 79:2565–2572.
  • Rappa KL, Rodriguez HF, Hakkarainen GC, Anchan RM, Mutter GL, Asghar W. 2016. Sperm processing for advanced reproductive technologies: where are we today? Biotechnol Adv. 34:578–587.
  • Roca A, Afolabi MO, Saidu Y, Kampmann B. 2015. Ebola: a holistic approach is required to achieve effective management and control. J Allergy Clin Immunol. 135:856–867.
  • Rodriguez L, De Roo A, Guimard Y, Trappier S, Sanchez A, Bressler D, Williams A, Rowe A, Bertolli J, Khan A. 1999. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 179:S170–S176.
  • Rogacs A, Qu Y, Santiago JG. 2012. Bacterial RNA extraction and purification from whole human blood using isotachophoresis. Anal Chem. 84:5858–5863.
  • Rossomando EF, White L, Ulfelder KJ. 1994. Capillary electrophoresis: separation and quantitation of reverse transcriptase polymerase chain reaction products from polio virus. J Chromatogr B: Biomed Sci Appl. 656:159–168.
  • Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum J, Bressler D, Williams A, Peters C, Rodriguez L, Feldmann H. 1999. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis. 179:S28–S35.
  • Safavieh M, Coarsey C, Esiobu N, Memic A, Vyas JM, Shafiee H, Asghar W. 2017. Advances in Candida detection platforms for clinical and point-of-care applications. Crit Rev Biotechnol. 37:441–458.
  • Safavieh M, Kanakasabapathy MK, Tarlan F, Tarlan F, Ahmed MU, Zourob M, Asghar W, Shafiee H. 2016. Emerging loop-mediated isothermal amplification-based microchip and microdevice technologies for nucleic acid detection. ACS Biomater Sci Eng. 2:278–294.
  • Saijo M, Niikura M, Ikegami T, Kurane I, Kurata T, Morikawa S. 2006. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol. 13:444–451.
  • Sanchez A, Kiley MP, Holloway BP, Auperin DD. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29:215–240.
  • Sanchez A, Ksiazek TG, Rollin PE, Miranda MEG, Trappier SG, Khan AS, Peters CJ, Nichol ST. 1999. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis. 179:S164–S169.
  • Sanchez A, Trappier SG, Mahy B, Peters CJ, Nichol ST. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci. 93:3602–3607.
  • Sano T, Smith CL, Cantor CR. 1992. Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. Science. 258:120–122.
  • Shafiee H, Asghar W, Inci F, Yuksekkaya M, Jahangir M, Zhang MH, Durmus NG, Gurkan UA, Kuritzkes DR, Demirci U. 2015a. Paper and flexible substrates as materials for biosensing platforms to detect multiple biotargets. Sci Rep. 5:8719.
  • Shafiee H, Asghar W, Inci F, Yuksekkaya M, Jahangir M, Zhang MH, Durmus NG, Gurkan UA, Kuritzkes DR, Demirci U. 2015b. Paper and flexible substrates as materials for biosensing platforms to detect multiple biotargets. Scientific reports.5.
  • Shafiee H, Kanakasabapathy M, Juillard F, Keser M, Sadasivam M, Hanhauser E, Henrich T, Kuritzkes D, Kaye K, Demirci U. 2015. Printed flexible plastic microchip for viral load measurement through quantitative detection of viruses in plasma and artificial saliva. Sci Rep. 4:9919
  • Shafiee H, Lidstone EA, Jahangir M, Inci F, Hanhauser E, Henrich TJ, Kuritzkes DR, Cunningham BT, Demirci U. 2014. Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci Rep. 4:4116.
  • Shahhosseini S, Das D, Qiu X, Feldmann H, Jones SM, Suresh MR. 2007. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. J Virol Methods. 143:29–37.
  • Sher M, Zhuang R, Demirci U, Asghar W. 2017. Paper-based analytical devices for clinical diagnosis: recent advances in the fabrication techniques and sensing mechanisms. Expert Rev Mol Diagnost. 17:351–366.
  • Singh JA. 2015. Humanitarian access to unapproved interventions in public health emergencies of international concern. PLoS Med. 12:e1001793.
  • Sozhamannan S, Holland MY, Hall AT, Negrón DA, Ivancich M, Koehler JW, Minogue TD, Campbell CE, Berger WJ, Christopher GW. 2015. Evaluation of signature erosion in Ebola virus due to genomic drift and its impact on the performance of diagnostic assays. Viruses. 7:3130–3154.
  • Strauss JH Jr, Sinsheimer RL. 1963. Purification and properties of bacteriophage MS2 and of its ribonucleic acid. J Mol Biol. 7:43–54.
  • Sun S, Yang M, Kostov Y, Rasooly A. 2010. ELISA-LOC: lab-on-a-chip for enzyme-linked immunodetection. Lab Chip. 10:2093–2100.
  • Sun Y, Dhumpa R, Bang DD, Høgberg J, Handberg K, Wolff A. 2011. A lab-on-a-chip device for rapid identification of avian influenza viral RNA by solid-phase PCR. Lab Chip. 11:1457–1463.
  • Suzuki Y, Gojobori T. 1997. The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol. 14:800–806.
  • Tambo E, Ugwu EC, Ngogang JY. 2014. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect Dis Poverty. 3:29. doi: 10.1186/2049-9957-3-29
  • Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH, Kotsopoulos SK, Samuels ML, Hutchison JB, Larson JW. 2009. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol. 27:1025–1031.
  • Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 78:4330–4341.
  • Towner JS, Sealy TK, Ksiazek TG, Nichol ST. 2007. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 196:S205–S212.
  • Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, et al 2010. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 82:954–960.
  • Vidyala SD, Asghar W, Iqbal SM. 2011. Porous organic nanolayers for coating of solid-state devices. J Nanobiotechnol. 9:1.
  • Wan Y, Liu Y, Allen PB, Asghar W, Mahmood MAI, Tan J, Duhon H, Kim Y-t, Ellington AD, Iqbal SM. 2012. Capture, isolation and release of cancer cells with aptamer-functionalized glass bead array. Lab Chip. 12:4693–4701.
  • Wang L, Asghar W, Demirci U, Wan Y. 2013. Nanostructured substrates for isolation of circulating tumor cells. Nano Today. 8:374–387.
  • Wang S, Tasoglu S, Chen PZ, Chen M, Akbas R, Wach S, Ozdemir CI, Gurkan UA, Giguel FF, Kuritzkes DR, et al. 2014. Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care. Sci Rep. 4:3796.
  • Wang ZL. 2011. Nanogenerators for self-powered devices and systems. Atlanta: Georgia Institute of Technology.
  • Weidmann M, Mühlberger E, Hufert FT. 2004. Rapid detection protocol for filoviruses. J Clin Virol. 30:94–99.
  • Whitehouse CA, Bavari S, Perkins MD. 2015. United States FDA’s emergency use authorization of Ebola virus diagnostics: current impact and lessons for the future. Expert Rev Mol Diagn. 15:1231–1235.
  • WHO. 2014. Laboratory Guidance for the Diagnosis of Ebola Virus Disease Interim Recommendations.
  • Woolley AT, Hadley D, Landre P, deMello AJ, Mathies RA, Northrup MA. 1996. Functional integration of PCR amplification and capillary electrophoresis in a microfabricated DNA analysis device. Anal Chem. 68:4081–4086.
  • Yang M, Sun S, Kostov Y, Rasooly A. 2010. Lab-on-a-chip for carbon nanotubes based immunoassay detection of Staphylococcal Enterotoxin B (SEB). Lab Chip. 10:1011–1017.
  • Yen C-W, de Puig H, Tam JO, Gomez-Marquez J, Bosch I, Hamad-Schifferli K, Gehrke L. 2015. Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip. 15:1638–1641.
  • Young CC, Proescher AJ, Smith EE. 2010. Purification and concentration of proteins and DNA from a complex sample using isotachophoresis and a device to perform the purification. Google Patents.
  • Yu J-S, Liao H-X, Gerdon AE, Huffman B, Scearce RM, McAdams M, Alam SM, Popernack PM, Sullivan NJ, Wright D, et al. 2006. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. J Virol Methods. 137:219–228.
  • Yun Y, Dong Z, Shanov V, Heineman WR, Halsall HB, Bhattacharya A, Conforti L, Narayan RK, Ball WS, Schulz MJ. 2007. Nanotube electrodes and biosensors. Nano Today. 2:30–37.
  • Zachariah R, Harries AD. 2015. The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry? Lancet Infect Dis. 15:989–990.
  • Zaki SR, Shieh W-J, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tshioko FK, Bwaka MA, Swanepoel R, Calain P, et al. 1999. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis. 179:S36–S47.
  • Zhang C, Xing D. 2007. Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends. Nucleic Acids Res. 35:4223–4237.
  • Zhang N, Appella DH. 2010. Advantages of peptide nucleic acids as diagnostic platforms for detection of nucleic acids in resource-limited settings. J Infect Dis. 201:S42–S45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.